VRHI (Veri Medtech Holdings) Research & Development: $ Mil (TTM As of Dec. 2021)


VRHI Veri Medtech Holdings Inc VRHI
35 GF Score
Price $1.95
View Full Analysis

What is Veri Medtech Holdings Research & Development?

Veri Medtech Holdings VRHI 35 Research & Development is $ Mil as of Dec. 2021. GuruFocus rates VRHI with a GF Score™ of 35/100.

Research & Development is the aggregate amount of research and development expenses during the year. Veri Medtech Holdings's Research & Development for the six months ended in Dec. 2021 was $0.00 Mil. Veri Medtech Holdings does not have enough years/quarters to calculate the Research & Development for the trailing twelve months (TTM) ended in Dec. 2021.

Veri Medtech Holdings  (OTCPK:VRHI) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Veri Medtech Holdings Research & Development Related Terms

Veri Medtech Holdings Research & Development Historical Data

* Premium members only.

The historical data trend for Veri Medtech Holdings's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Veri Medtech Holdings Research & Development Chart

Veri Medtech Holdings Annual Data
Trend Dec21
Research & Development
0.00

Veri Medtech Holdings Semi-Annual Data
Dec21
Research & Development 0.00
VRHI
35GF Score
Veri Medtech Holdings Inc VRHI
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Veri Medtech Holdings Research & Development Calculation

This is the expense the company spent on research and development.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of $ Mil mean?
Veri Medtech Holdings (VRHI) has a Research & Development of $ Mil as of Dec. 2021. Research and development expense is the total cost for research and development activities. View historical data on Veri Medtech Holdings and its competitors.
Is Veri Medtech Holdings' Research & Development too high?
Veri Medtech Holdings' current Research & Development is $ Mil. Overall, Veri Medtech Holdings has a GF Score™ of 35/100, reflecting its overall financial health beyond just this single metric.
How does Veri Medtech Holdings' Research & Development compare to MMVVF and BLMZ?
Veri Medtech Holdings' Research & Development of $ Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Healthcare Providers & Services company?
A good Research & Development depends on the Healthcare Providers & Services industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Veri Medtech Holdings and its competitors. Veri Medtech Holdings's current Research & Development is $ Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Veri Medtech Holdings stock overvalued right now?
Veri Medtech Holdings (VRHI) has a current Research & Development of $ Mil. The current Research & Development is $ Mil. Veri Medtech Holdings' overall GF Score™ is 35/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Veri Medtech Holdings (VRHI), the current Research & Development is $ Mil as of Dec. 2021. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Veri Medtech Holdings Business Description

Address 1660 International Drive, Suite 600, McClean, VA, USA, 22101
Veri Medtech Holdings Inc is a healthcare technology company that offers alternative medicine, personalized diagnostics, and wellness medication on demand. The company leverages telehealth infrastructure, diagnostic intelligence, and scalable digital systems to meet the growing demand for accessible, stigma-free healthcare. Strategically positioned for growth, Veri MedTech actively explores acquisitions that complement its core capabilities and enhance patient engagement across emerging sectors of alternative medicine, longevity, and wellness science. With an integration and operational efficiency track record, the company drives accelerated revenue through the continuous generation of high-value patient databases and recurring service models.
35GF Score

Get the complete analysis for VRHI

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$1.95
Price